Drug intelligence / Profile preview

dieckol

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Dieckol is a **phlorotannin**, a type of marine polyphenol compound isolated mainly from brown algae including *Ecklonia cava*, *Ecklonia stolonifera*, and *Eisenia bicyclis*. It exhibits a range of bioactivities, including **antioxidant**, **anticoagulant**, **hepatoprotective**, **antimicrobial**, **anticancer**, **antiaging**, **antidiabetic**, **neuroprotective**, and anti-inflammatory properties[1][5][8][9]. Mechanistically, dieckol acts as a **positive allosteric modulator** at the benzodiazepine (BZD) binding site of **GABA-A receptor**, enhancing non-REM sleep in preclinical models[3]. It is also reported to inhibit **alpha-glucosidase**, **PI3K/AKT signaling** (relevant in cancer cell proliferation), and **platelet aggregation/thrombosis**[1][3][9]. Dieckol is under investigation for a variety of potential uses including in the food, pharmaceutical, and cosmetic industries, but is not an approved pharmaceutical drug[5].

Other names
Dieckol8,4'''-Dieckol4-[4-[6-(3,5-dihydroxyphenoxy)-4,7,9-trihydroxydibenzo-p-dioxin-2-yl]oxy-3,5-dihydroxyphenoxy]dibenzo-p-dioxin-1,3,6,8-tetrol4-(4-((6-(3,5-Dihydroxyphenoxy)-4,7,9-trihydroxydibenzo[b,e][1,4]dioxin-2-yl)oxy)-3,5-dihydroxyphenoxy)dibenzo[b,e][1,4]dioxin-1,3,6,8-tetrol
02

Targets

Sucrase-IsomaltaseAKT (RAC-alpha serine/threonine-protein kinase)GABAA (Gamma-aminobutyric acid receptor)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)

Beyond the preview

Go deeper on dieckol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dieckol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call